fbpx
X
Popular Searches
Hemato-Oncology Cancer Treatment Rehabilitation Children Cancer Treatment CAR T THERAPY

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
x New Patient Current or Returning Refer a patient
search
stethoscope
Ivetta Danylesko

Ivetta Danylesko

  • MD
Department:
  • Hematooncology Division
Specialties:
  • Bone Marrow Transplantation
Languages:
  • English
  • Hebrew
  • Russian
Request Consultation

About

Dr. Ivetta Danylesko is an attending physician at the Bone Marrow Transplant Unit of Hemato oncology Division.

She has completed with honor her medical education at the Georgievsky Crimia State Medical University in 1997. Then she specialized in Infectious Diseases. She has completed her clinical fellowship and lectured at the Department of Infectious Diseases.

Dr. Danylesko repatriated to Israel in 2001. After her repatriation she specialized in Internal Medicine and Hematology.

Dr. Danylesko actively participates in international EHA, EBMT and ASH congresses.

Dr. Danylesko publishes in scientific journals and lectures to students. She was awarded the title of lecturer at Tel Aviv University in 2017. As for now she is trying to achieve the title of senior lecturer.

Conditions and treatment

Positions

  • Leading physician at the BMT Unit
  • Lecturer at Sackler Medical School of the Tel Aviv University

Education and Training

  • Completed with honor her medical education at the Georgievsky Crimia State Medical University
  • Specialized in Infectious Diseases, the Georgievsky Crimia State Medical University
  • Clinical fellowship at the Department of Infectious Diseases, the Georgievsky Crimia State Medical University
  • Specialized in Internal Medicine and Hematology

Board Certifications

  • Internal medicine
  • Hematology

Publications

Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease.Danylesko I, Bukauskas A, Paulson M, Peceliunas V, Gedde-Dahl D Y T, Shimoni A, Shouval R, Griskevicius L, Floisand Y, Nagler A.

The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation. Fein JA, Shimoni A, Labopin M, Shem-Tov N, Yerushalmi R, Magen H, Furie N, Kopel E, Danylesko I, Nagler A, Shouval R.

Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality. Shouval R, de Jong CN, Fein J, Broers AEC, Danylesko I, Shimoni A, Reurs MR, Baars AE, van der Schaft N, Nagler A, Cornelissen JJ.

All publications

Sheba Knowledge Base

Request a consultation

Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.

We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.

Request a consultation and a Sheba Case Manager will contact you shortly:

New Patient Current & Returning Patients Refer a Patient